article

Delivering a therapy to kerb COVID-19

Sheraz Gul explores current research developments to help treat and tackle the spread of COVID-19.

Red coronavirs particles attacking a globe

Since publication of Drug Target Review Issue 1 in Spring 2020, the global impact of the highly contagious coronavirus disease 2019 (COVID-19) has been unparalleled. As there is no approved therapy available to treat the virus, the main effort to tackle its spread was to restrict the movement of individuals – and this strategy largely remains in place. However, the only sure-footed ways to kerb the spread of COVID-19 are to develop a vaccine and treat those who have contracted the disease with a suitable therapy – both of which need to be safe and efficacious.











    To read this article in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


    *

    *

    *

    *

    *

    *

    *

    *

    Send this to a friend